A drug created by the company Biogen might be able to slow the progression of Alzheimer's Disease.
The company initially discontinued work on aducanumab when it started with disappointing results. They now say that a further analysis of that same data has actually suggested it may decrease cognitive loss in its treatment of Alzheimer's Disease.
Dr. Andrew Frank of Bruyère spoke about it yesterday on CFRA. Dr. Frank suggests further trials will be necessary, but that this remains a positive development in the world of dementia.
If you look up the definition of ‘volunteer’, it simply states, “Freely offer to do something.” Although true, this doesn’t sufficiently capture those who volunteer. I’ve been a Volunteer Coordinator with the Dementia Society of Ottawa and Renfrew Cou
The statistics are alarming: one of the greatest risk factors for dying of COVID-19 is dementia. The reasons are many and potentially complex, but the need to prioritize the 24,000+ people diagnosed with dementia in Ottawa and Renfrew County and their